Boult Wade Tennant
/bulletin

Archives: Bulletins

August 28, 2020

Renewal fee increases in Australia

The Australian Patent Office will be changing various official fees for patents, trademarks and designs from 1 October 2020. Notably, patent renewal

August 11, 2020

Neurim Overturned – CJEU severely restricts availability of second medical use SPCs

The Court of Justice of the European Union (CJEU) has ruled in Santen (C‑673/18) that a Supplementary Protection Certificate (SPC) cannot be

August 4, 2020

Apportionment of costs at oral proceedings

Oral Proceedings are a common occurrence during the opposition procedure at the European Patent Office.  Importantly, these proceedings provide the patentee and

July 25, 2020

Emson v. Hozelock: Public prior use and a “mere paper proposal”

On 8 July 2020, the Court of Appeal issued its decision in the Emson v. Hozelock case ([2020] EWCA Civ 871). The

July 19, 2020

Patentability of simulations – Decision of the Enlarged Board of Appeal for G1/19.

The thorny issue of the patentability (or otherwise) of inventions involving computer simulations at the EPO has been provided with an ending,

July 14, 2020

The CJEU Confirms that Copyright Can Cover Products Designed to Achieve a Technical Result

When does a technical product become eligible for copyright protection? This is the question the Court of Justice of the European Union

July 3, 2020

Criteria for basing SPCs on functional claims clarified by CJEU in Royalty Pharma

In the latest of a series of judgments concerning the interpretation of Article 3(a) of the SPC Regulation, the Court of Justice

June 17, 2020

Reaffirmation of the Allowability of Technical Implementations of Business Methods at the EPO

On 3 April 2020, the Technical Board of Appeal of the European Patent Office issued a decision for Appeal T1749/14 against refusal

June 10, 2020

Special reasons? Remittals from the EPO Boards of Appeal

One of the changes to the Rules of Procedure of the Boards of Appeal (RPBA) which came into force on 1 January

June 4, 2020

The EPO rules that plants and animals exclusively obtained by essentially biological processes are not patentable

The Enlarged Board of Appeal (EBA) of the EPO has confirmed in decision G3/19 that plants, plant material or animals exclusively obtained